Thomas Sciascia - Net Worth and Insider Trading
Thomas Sciascia Net Worth
The estimated net worth of Thomas Sciascia is at least $647,726 dollars as of 2024-11-05. Thomas Sciascia is the Chief Scientific Officer of Trevi Therapeutics Inc and owns about 220,315 shares of Trevi Therapeutics Inc (TRVI) stock worth over $647,726. Details can be seen in Thomas Sciascia's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Thomas Sciascia has not made any transactions after 2024-08-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Thomas Sciascia
Thomas Sciascia Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Thomas Sciascia owns 1 companies in total, including Trevi Therapeutics Inc (TRVI) .
Click here to see the complete history of Thomas Sciascia’s form 4 insider trades.
Insider Ownership Summary of Thomas Sciascia
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TRVI | Trevi Therapeutics Inc | 2024-08-19 | 10 percent owner & Chief Medical Officer |
Thomas Sciascia Latest Holdings Summary
Thomas Sciascia currently owns a total of 1 stock. Thomas Sciascia owns 220,315 shares of Trevi Therapeutics Inc (TRVI) as of August 19, 2024, with a value of $647,726.
Latest Holdings of Thomas Sciascia
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TRVI | Trevi Therapeutics Inc | 2024-08-19 | 220,315 | 2.94 | 647,726 |
Holding Weightings of Thomas Sciascia
Thomas Sciascia Form 4 Trading Tracker
According to the SEC Form 4 filings, Thomas Sciascia has made a total of 3 transactions in Trevi Therapeutics Inc (TRVI) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Trevi Therapeutics Inc is the sale of 16,496 shares on August 19, 2024, which brought Thomas Sciascia around $48,828.
Insider Trading History of Thomas Sciascia
- 1
Thomas Sciascia Trading Performance
Thomas Sciascia Ownership Network
Ownership Network List of Thomas Sciascia
Ownership Network Relation of Thomas Sciascia
Thomas Sciascia Owned Company Details
What does Trevi Therapeutics Inc do?
Who are the key executives at Trevi Therapeutics Inc?
Thomas Sciascia is the 10 percent owner & Chief Medical Officer of Trevi Therapeutics Inc. Other key executives at Trevi Therapeutics Inc include director & 10 percent owner & See Remarks Jennifer L Good , director & 10 percent owner David P Meeker , and Chief Financial Officer Lisa Delfini .
Trevi Therapeutics Inc (TRVI) Insider Trades Summary
Over the past 18 months, Thomas Sciascia made 3 insider transaction in Trevi Therapeutics Inc (TRVI) with a net sale of 101,369. Other recent insider transactions involving Trevi Therapeutics Inc (TRVI) include a net sale of 8,387 shares made by Lisa Delfini , a net sale of 90,795 shares made by Jennifer L Good , and a net sale of 4,555 shares made by David P Meeker .
In summary, during the past 3 months, insiders sold 113,736 shares of Trevi Therapeutics Inc (TRVI) in total and bought 0 shares, with a net sale of 113,736 shares. During the past 18 months, 205,106 shares of Trevi Therapeutics Inc (TRVI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 205,106 shares.
Trevi Therapeutics Inc (TRVI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Trevi Therapeutics Inc Insider Transactions
Thomas Sciascia Mailing Address
Above is the net worth, insider trading, and ownership report for Thomas Sciascia. You might contact Thomas Sciascia via mailing address: 39 Old Ridgebury Rd. Suite 11, Danbury Ct 06810.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
